AKAN | Akanda Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.3200 - 1.4200
52 Week Range	1.2200 - 47.52
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	16,181
Average Volume	71,267
Shares Outstanding	2,047,332
Market Cap	2,825,318
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2022-03-15

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	-524.76
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	46
Country	UK
Website	AKAN

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

AKAN's peers: SXTC, PTPI, GSAC, SHPH, DBCCF, CXXIF, CLSH, GRUSF, SLGWF, LSDI, LFCR, DERM, CPHI, UPC, SNOA, ACOR, BFRI, GHSI, CPIX, EBS, EVOK, HTCR, KALA, KMDA, SCYX

*Chart delayed

Analyzing fundamentals for AKAN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see AKAN Fundamentals page.

Watching at AKAN technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on AKAN Technicals page.